// App-Quantinova.ai

755P : Prognostic value of neutrophil-lymphocyte ratio in first line treatment for metastatic pancreatic adenocarcinoma

Researchers

Presenter

  • Y.S.Rho

Principal Investigators

  • J.Ranger

  • S.Hamalova

  • I.Barrera

  • A.Mamo

  • G.Batist

  • P.Kavan

Medical Centers

  • Internal Medicine, University of Hawaii, Honolulu, HI, USA

  • Department of Oncology, McGill University and the Segal Cancer Center, Sir Mortimer B. Davis, Jewish General Hospital, Montreal, QC, Canada

Locations

  • United States

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Gastroenterology (GU)

Disease

  • N/A

Biomarkers

  • Neutrophil lymphocyte ratio

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved